Home
>
National Drug Code (NDC)
>
Vandetanib
Vandetanib - 0310-7830-30 - (Vandetanib)
Drug Information of Vandetanib
| Product NDC: | 0310-7830 |
| Proprietary Name: | Vandetanib |
| Non Proprietary Name: | Vandetanib |
| Active Ingredient(s): | 300 mg/1 & nbsp; Vandetanib |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Vandetanib
| Product NDC: | 0310-7830 |
| Labeler Name: | AstraZeneca Pharmaceuticals LP |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022405 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20110421 |
Package Information of Vandetanib
| Package NDC: | 0310-7830-30 |
| Package Description: | 30 TABLET in 1 BOTTLE, PLASTIC (0310-7830-30) |
NDC Information of Vandetanib
| NDC Code | 0310-7830-30 |
| Proprietary Name | Vandetanib |
| Package Description | 30 TABLET in 1 BOTTLE, PLASTIC (0310-7830-30) |
| Product NDC | 0310-7830 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Vandetanib |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20110421 |
| Marketing Category Name | NDA |
| Labeler Name | AstraZeneca Pharmaceuticals LP |
| Substance Name | VANDETANIB |
| Strength Number | 300 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] |
